Showing 1911-1920 of 10609 results for "".
Revenue Cycle Management: What Physicians and Administrators Need to Know
https://practicaldermatology.com/topics/practice-management/revenue-cycle-management-what-physicians-and-administrators-need-to-know/23536/The latest generation of RCM software can benefit practices in multiple ways.The Benefits of Financial Forecasting in Uncertain Times
https://practicaldermatology.com/topics/practice-management/the-benefits-of-financial-forecasting-in-uncertain-times/23528/Steps for planning for the future to bring back some sense of control.Gene Biomarker Research and Implications for Care
https://practicaldermatology.com/topics/psoriasis/gene-biomarker-research-and-implications-for-care/23374/A tape strip test can differentiate psoriasis from atopic dermatitis based on genetic analysis. How may the finding affect care?Building Dermatology Patient Relationships with AI Chat and Text Messaging
https://practicaldermatology.com/topics/practice-management/building-dermatology-patient-relationships-with-ai-chat-and-text-messaging/23188/Automated communication tools could actually be the secret to a personal touch.Dermatology Patients Ask Google. But Who Answers?
https://practicaldermatology.com/topics/practice-management/dermatology-patients-ask-google-but-who-answers/23165/Despite dermatologists’ expertise, their sites may not rank highest in search for skin health topics.Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Emerging Business Concept: The Acne Treatment Center
https://practicaldermatology.com/topics/practice-management/emerging-business-concept-the-acne-treatment-center/20700/What if there was a practice devoted solely to the treatment of acne and acne scars?Therapies in Practice: New Options for Ichthyosis Vulgaris
https://practicaldermatology.com/topics/general-topics/therapies-in-practice-new-options-for-ichthyosis-vulgaris/21933/Emerging data confirm that atopic dermatitis and ichthyosis share pathogenic traits, suggesting a role for barrier repair formulations in management.In The Pipeline: Phase 1, 2, and 3
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/pipeline-phase-1-2-and-3/29087/This summary provides the latest news on of some of the recent Phase 1, Phase 2, and Phase 3 clinical studies for psoriasis treatments.The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.